Fulgent Genetics, Inc.
NASDAQ:FLGT
Overview | Financials
Company Name | Fulgent Genetics, Inc. |
Symbol | FLGT |
Currency | USD |
Price | 22.02 |
Market Cap | 667,133,334 |
Dividend Yield | 0% |
52-week-range | 18.76 - 30.68 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Ming Hsieh |
Website | https://www.fulgentgenetics.com |
An error occurred while fetching data.
About Fulgent Genetics, Inc.
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD